Veeva Systems Inc. (VEEV) – What Are Investment Firms Thinking About This Stock?

Veeva Systems Inc. (NYSE:VEEV) has received a consensus recommendation of “Moderate Buy” from the twenty-eight analysts that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and nineteen have assigned a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $293.21.

Several analysts have recently weighed in on VEEV shares. Wall Street Zen upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. Stifel Nicolaus set a $300.00 target price on shares of Veeva Systems in a research report on Thursday, August 27th. Wells Fargo & Company reissued an “overweight” rating and set a $330.00 target price on shares of Veeva Systems in a research note on Tuesday, September 8th. Barclays raised their price target on shares of Veeva Systems from $360.00 to $375.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $295.00 price target on shares of Veeva Systems in a research note on Thursday, August 27th.

Veeva Systems Price Performance

NYSE VEEV opened at $310.24 on Friday. The business has a 50 day simple moving average of $282.72 and a 200 day simple moving average of $209.39. Veeva Systems has a one year low of $148.05 and a one year high of $325.99. The stock has a market capitalization of $50.23 billion, a P/E ratio of 51.34, a P/E/G ratio of 1.36 and a beta of 0.93.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $2.23 by $0.12. The business had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%. The firm’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Equities analysts expect that Veeva Systems will post 6.70 earnings per share for the current year.

Key Stories Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: AI adoption remains a major growth catalyst. At its Commercial Summit Europe, Veeva highlighted AI-driven CRM, conversational tools, Commercial Cloud and Data Cloud innovations designed to improve healthcare-professional engagement, content approval and medical decision-making. Customer examples from AstraZeneca, Bristol Myers Squibb and Roche support the potential for broader adoption among large biopharmaceutical companies. AI CRM Adoption Could Be A Key Catalyst For Veeva Systems Stock
• Positive Sentiment: Analysts continue to raise their valuation expectations. Barclays lifted its price target to $375 from $360 and maintained an overweight rating, while Mizuho raised its target to $345 from $280. These moves signal confidence in Veeva’s growth outlook and AI-enabled product strategy. Barclays Price Target Increase Mizuho Price Target Increase
• Positive Sentiment: Investors are positioned for continued earnings growth. Analysts expect double-digit growth in the upcoming fiscal Q3 2027 report, while Veeva’s latest reported quarter exceeded consensus estimates for both revenue and earnings. What to Expect From Veeva Systems Q3 2027 Earnings Report
• Neutral Sentiment: Valuation is creating a debate. Veeva has recently generated strong momentum, but its high earnings multiple means the stock may be sensitive to guidance, margins and the pace of AI monetization in the upcoming results.
• Negative Sentiment: Recent gains may be prompting profit-taking. With shares near their 52-week high after substantial one- and three-month advances, investors may be locking in gains ahead of earnings, particularly if expectations for AI-driven growth are already reflected in the valuation. Veeva Systems Heads Into Q3 Results

Insider Activity at Veeva Systems

In other news, EVP Daniel Rizzo sold 4,841 shares of the stock in a transaction dated Friday, October 2nd. The shares were sold at an average price of $276.51, for a total transaction of $1,338,584.91. Following the transaction, the executive vice president owned 7,665 shares of the company’s stock, valued at $2,119,449.15. This represents a 38.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of $261.04, for a total value of $195,780.00. Following the completion of the sale, the director owned 3,242 shares of the company’s stock, valued at approximately $846,291.68. This represents a 18.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 56,789 shares of company stock worth $14,913,889 over the last quarter. Company insiders own 10.60% of the company’s stock.

Institutional Investors Weigh In On Veeva Systems

Hedge funds have recently added to or reduced their stakes in the company. Principal Financial Group Inc. lifted its position in Veeva Systems by 7.0% in the 1st quarter. Principal Financial Group Inc. now owns 4,141,545 shares of the technology company’s stock valued at $727,513,000 after acquiring an additional 271,252 shares in the last quarter. Swedbank AB raised its stake in shares of Veeva Systems by 43.5% in the first quarter. Swedbank AB now owns 1,645,128 shares of the technology company’s stock worth $288,983,000 after purchasing an additional 498,971 shares during the last quarter. Pictet Asset Management Holding SA raised its stake in shares of Veeva Systems by 43.6% in the first quarter. Pictet Asset Management Holding SA now owns 1,593,795 shares of the technology company’s stock worth $279,970,000 after purchasing an additional 483,720 shares during the last quarter. Amundi raised its stake in shares of Veeva Systems by 8.0% in the first quarter. Amundi now owns 992,977 shares of the technology company’s stock worth $174,426,000 after purchasing an additional 73,510 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of Veeva Systems by 203.0% in the first quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company’s stock valued at $160,427,000 after purchasing an additional 611,868 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

About Veeva Systems

Veeva Systems Inc is a cloud software company that develops technology for the life sciences industry. Its customers include pharmaceutical, biotechnology, medical device and other healthcare companies that use Veeva’s applications to manage commercial, clinical, regulatory, quality and operational processes.

The company’s Veeva Vault platform provides cloud applications for areas such as clinical data management, electronic trial management, regulatory information, quality management, safety and content management.